Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936312 · ClinicalTrials.gov registry record
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
A clinical trial of Hemophilia A and Hemophilia B, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 200
- Enrollment target
- 11
- Study locations
NCT00936312 is a study of Hemophilia A and Hemophilia B that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants, above the 87-participant average among 42 other Hemophilia A trials with a reported enrollment target (130% higher). The trial reports 11 study locations across 3 states.
The verdict
NCT00936312, a study of Hemophilia A and Hemophilia B, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 11
- Study locations
Study Summary
This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.
Conditions Studied
Study Locations (11)
Other
- Princess Margaret Hospital for Children - Perth
- University Clinic Bonn - Bonn
- University Clinic Munich - Munich
- Sheba Medical Center - Tel Litwinsky
- Instituto G. Gaslini - Genova
- A. Bianchi Bonomi Hemophilia Center - Milan
- Nara Medical University - Nara
- University Hospital Utrecht - Utrecht
- Malmo University Hospital - Malmo
New York
- Weill Cornell Medical College - New York
Changhua
- Changhua Christian Hospital - Chunghua City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00936312
The ClinicalTrials.gov registry entry for NCT00936312 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 42 other Hemophilia A trials with a reported enrollment target (130% higher). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hemophilia A appearing as the primary indexed condition, and to 0 interventions.
NCT00936312 reports 11 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Changhua.
Frequently Asked Questions
What is clinical trial NCT00936312 about?
NCT00936312 is a clinical study titled "Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study". This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.
What is the current status of trial NCT00936312?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-03. Estimated completion is 2011-08.
What conditions does trial NCT00936312 study?
This clinical trial studies the following conditions: Hemophilia A, Hemophilia B.
Who is sponsoring clinical trial NCT00936312?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00936312 being conducted?
This trial has 11 study locations across New York, Changhua. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia A
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
RECRUITING · Phase 3
-
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
RECRUITING · Phase 3
-
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RECRUITING · Phase 1
-
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
RECRUITING · Phase 4
-
Hemophilia A Research Program
RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.